AVGO vs IKT · P/E 87, rev $63.89B vs $215.2M cap
Broadcom Inc (AVGO) versus Inhibikase Therapeutics Inc (IKT) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock E. Tan.
Inhibikase Therapeutics Inc (IKT) is a biotechnology company listed on US.
Latest reported AVGO revenue for 2025-11-02 was $63.89B. Net income was $23.13B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. IKT currently screens at market cap $215.2M.
Not investment advice. Open the AVGO and IKT stock pages for the full models.
Not investment advice.